Carlo Croce, M.D.
The award honors pioneering scientists who have made outstanding scientific contributions in the field of cancer research. The award, which includes a $25,000 honorarium, is designed to draw attention to the continued need to support basic cancer research and the role that it plays in new cancer therapies.
Croce, who is a member of the molecular biology and cancer genetics program in The Ohio State University Comprehensive Cancer Center, is recognized as one of the world’s leading experts in discovering cancer-related genes. Croce and his colleagues were the first to discover alterations in the microRNA genes of human cancers and the first to show that the expression of these genes can be used in cancer diagnosis and prognosis.
“Dr. Croce’s findings have once again expanded our understanding of the genesis of cancer and provided important tools for cancer diagnosis and exciting future opportunities for a more personalized approach to cancer treatment,” says Dr. Michael Caligiuri, director of Ohio State’s Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute.
The National Foundation of Cancer Research presented the award to Croce at the annual Cancer Progress Conference in New York City in March.